Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6778)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2018 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhao QJ, Zhang J, Xu L, Liu FF. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. World J Gastroenterol 2018; 24(30): 3426-3439 [PMID: 30122881 DOI: 10.3748/wjg.v24.i30.3426] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i30/3426.htm |
| Number | Citing Articles |
| 1 |
Weihao Kong, Xingyu Wang, Xiaomin Zuo, Zhongxiang Mao, Ya Cheng, Wei Chen. Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.01037
|
| 2 |
Ying Sun, Xiaoyuan Zheng, Hui Yuan, Geng Chen, Jiahe Ouyang, Jingfeng Liu, Xiaolong Liu, Xiaohua Xing, Bixing Zhao. Proteomic analyses reveal divergent ubiquitylation patterns in hepatocellula carcinoma cell lines with different metastasis potential. Journal of Proteomics 2020; 225: 103834 doi: 10.1016/j.jprot.2020.103834
|
| 3 |
Tao Wang, Zhijia Zhou, Xuan Wang, Liping You, Wenxuan Li, Chao Zheng, Jinghao Zhang, Lingtai Wang, Xiaoni Kong, Yueqiu Gao, Xuehua Sun. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.929035
|
| 4 |
Yifan Wang, Lutao Du, Xuemei Yang, Juan Li, Peilong Li, Yinghui Zhao, Weili Duan, Yingjie Chen, Yunshan Wang, Haiting Mao, Chuanxin Wang. A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer. Aging 2020; 12(3): 2857 doi: 10.18632/aging.102782
|
| 5 |
Yuan Fang, Yang Yang, XiaoLi Zhang, Na Li, Bo Yuan, Li Jin, Sheng Bao, MengGe Li, Dan Zhao, LingRui Li, Zhong Zeng, HanFei Huang. A Co-Expression Network Reveals the Potential Regulatory Mechanism of lncRNAs in Relapsed Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.745166
|
| 6 |
Benyuan Deng, Min Yang, Ming Wang, Zhongwu Liu. Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma. Medicine 2020; 99(21): e20422 doi: 10.1097/MD.0000000000020422
|
| 7 |
Cheng Chen, Na Su, Guiying Li, Yanfeng Shen, Xiaoting Duan. Long non‑coding RNA TMCC1‑AS1 predicts poor prognosis and accelerates epithelial‑mesenchymal transition in liver cancer. Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13034
|
| 8 |
Huiyuan Qiu, Bo Jiang, Yinqi Chen, Zhaoyi Lin, Wenjie Zheng, Xiaolei Cao. Featured lncRNA-based signature for discriminating prognosis and progression of hepatocellular carcinoma. Journal of Applied Genetics 2024; 65(2): 355 doi: 10.1007/s13353-024-00836-5
|
| 9 |
Zhong Fang, Xiaoyu Yu, Shuangmei Tong, Chuan Lu, Yuxian Huang, Liang Chen, Zhenghong Yuan, Yi Zhang. Serum ERK1/2 proteins fluctuating with HBV infection report frequency of viral-specific CD8+ T cells and predict IFNα therapeutic effect in chronic hepatitis B patients. Clinical Immunology 2020; 219: 108570 doi: 10.1016/j.clim.2020.108570
|
| 10 |
Xuelian Huang, Sicong Zhu, Kelin Zhang, Wenliang Tan, Yajin Chen, Changzhen Shang. High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.814058
|
| 11 |
Jie Gu, Xiaobo Zhang, ZhangZhe Peng, Zhuoming Peng, Zhouning Liao. A novel immune-related gene signature for predicting immunotherapy outcomes and survival in clear cell renal cell carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-45966-8
|
| 12 |
Daojie Yan, Fengwei Jin, Yufeng Lin. lncRNA HAND2-AS1 Inhibits Liver Cancer Cell Proliferation and Migration by Upregulating SOCS5 to Inactivate the JAK-STAT Pathway. Cancer Biotherapy and Radiopharmaceuticals 2020; 35(2): 143 doi: 10.1089/cbr.2019.2958
|
| 13 |
Xichun Liu, Xing Niu, Zhigang Qiu. A Five-Gene Signature Based on Stromal/Immune Scores in the Tumor Microenvironment and Its Clinical Implications for Liver Cancer. DNA and Cell Biology 2020; 39(9): 1621 doi: 10.1089/dna.2020.5512
|
| 14 |
Lingpeng Yang, Yang He, Zifei Zhang, Wentao Wang. Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas. PeerJ 2019; 7: e8245 doi: 10.7717/peerj.8245
|
| 15 |
Lan Jiang, Xiaolong Zhu, Hui Yang, Tianbing Chen, Kun Lv. Bioinformatics Analysis Discovers Microtubular Tubulin Beta 6 Class V (TUBB6) as a Potential Therapeutic Target in Glioblastoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.566579
|
| 16 |
Linkun Ma, Cunliang Deng. Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma. PeerJ 2019; 7: e7413 doi: 10.7717/peerj.7413
|
| 17 |
Chuan Jin, Jian-Sen Zhao, Xu-Qi Huang, Xian-Zi Yang, Fei-Yu Niu, Jin-Rong Lin, Lei Ma, Yan-Xia Shi, Xiao-Shan Li, Peng Jiang, Sha Gao, Feng Li, Ye Song. A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma. Hepatology International 2022; 16(5): 1220 doi: 10.1007/s12072-022-10375-y
|
| 18 |
Qing Lin, Hongying Zheng, Jianjun Xu, Feng Zhang, Huazheng Pan. LncRNA SNHG16 aggravates tumorigenesis and development of hepatocellular carcinoma by sponging miR‐4500 and targeting STAT3. Journal of Cellular Biochemistry 2019; 120(7): 11604 doi: 10.1002/jcb.28440
|
| 19 |
Kaikai Ren, Jiakang Ma, Bo Zhou, Xiaoyan Lin, Mingyu Hou, Ling Zhang, Ling Yuan, Jun Ma. Identification of prognostic and immune-related lncRNAs in hepatocellular carcinoma based on the cancer genome atlas data mining. Materials Express 2020; 10(8): 1189 doi: 10.1166/mex.2020.1736
|
| 20 |
Xuemei Yang, Juan Li, Yifan Wang, Peilong Li, Yinghui Zhao, Weili Duan, Abakundana Nsenga Ariston Gabriel, Yingjie Chen, Haiting Mao, Yunshan Wang, Lutao Du, Chuanxin Wang. Individualized Prediction of Survival by a 10-Long Non-coding RNA-Based Prognostic Model for Patients With Breast Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.515421
|
| 21 |
Hao Wu, Tian Tian Liu, Yue Min Feng, Xiao Yu Xie, Xiao Nan Su, Jian Ni Qi, Qiang Zhu, Cheng Yong Qin. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus‐related hepatocellular carcinoma after hepatectomy. Journal of Digestive Diseases 2020; 21(11): 650 doi: 10.1111/1751-2980.12941
|
| 22 |
Peng Qin, Mengyu Zhang, Xue Liu, Ziming Dong, Fazlullah Khan. Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma. Journal of Healthcare Engineering 2021; 2021: 1 doi: 10.1155/2021/3761858
|
| 23 |
Jun Liu, Jianjun Lu, Zhanzhong Ma, Wenli Li. A Nomogram Based on a Three-Gene Signature Derived from AATF Coexpressed Genes Predicts Overall Survival of Hepatocellular Carcinoma Patients. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/7310768
|
| 24 |
Hugo Pinto-Marques, Joana Cardoso, Sílvia Silva, João L. Neto, Maria Gonçalves-Reis, Daniela Proença, Marta Mesquita, André Manso, Sara Carapeta, Mafalda Sobral, Antonio Figueiredo, Clara Rodrigues, Adelaide Milheiro, Ana Carvalho, Rui Perdigoto, Eduardo Barroso, José B. Pereira-Leal. A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation. Annals of Surgery 2022; 276(5): 868 doi: 10.1097/SLA.0000000000005637
|
| 25 |
Yifei Dai, Weijie Qiang, Kequan Lin, Yu Gui, Xun Lan, Dong Wang. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma. Cancer Immunology, Immunotherapy 2021; 70(4): 967 doi: 10.1007/s00262-020-02743-0
|
| 26 |
Chengli Liu, Meng Pu, Yingbo Ma, Cheng Wang, Linghong Kong, Shuhan Zhang, Xuying Zhao, Xiaopeng Lian. Intra-tumor heterogeneity and prognostic risk signature for hepatocellular carcinoma based on single-cell analysis. Experimental Biology and Medicine 2022; 247(19): 1741 doi: 10.1177/15353702221110659
|
| 27 |
Qingguo Mo, Wenjing Li, Lin Liu, Zhidong Hao, Shengjun Jia, Yongsheng Duo. A nomogram based on 4-lncRNAs signature for improving prognostic prediction of hepatocellular carcinoma. Clinical and Translational Oncology 2023; 26(2): 375 doi: 10.1007/s12094-023-03244-z
|
| 28 |
Yi Fu, Anfeng Si, Xindong Wei, Xinjie Lin, Yujie Ma, Huimin Qiu, Zhinan Guo, Yong Pan, Yiru Zhang, Xiaoni Kong, Shibo Li, Yanjun Shi, Hailong Wu. Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma. BMC Genomics 2023; 24(1) doi: 10.1186/s12864-023-09194-8
|
| 29 |
Wen Jiang, Qing Guo, Chenghe Wang, Yu Zhu. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0928-5
|
| 30 |
Wei Hu, Hui Feng, Xiaoyu Xu, Xin Huang, Xingyue Huang, Wenwei Chen, Lidan Hao, Wenfang Xia. Long noncoding RNA FOXD2‐AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR‐206/MAP3K1 axis. Cancer Medicine 2020; 9(15): 5620 doi: 10.1002/cam4.3204
|
| 31 |
Ting Lei, Xiaodong Zhu, Kai Zhu, Fuxin Jia, Siqiao Li. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway. Cancer Biology & Therapy 2019; 20(7): 1007 doi: 10.1080/15384047.2019.1595276
|
| 32 |
Zixuan Zhong, Minxuan Xu, Jun Tan. Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma. Pathology and Oncology Research 2022; 28 doi: 10.3389/pore.2022.1610670
|
| 33 |
Zhu Liangyu, Zhang Bochao, Yin Guoquan, Zhang Yuan, Li Heng, Zhou Hanyu. Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma. Biochemistry and Biophysics Reports 2023; 35: 101502 doi: 10.1016/j.bbrep.2023.101502
|
| 34 |
Fujiao Duan, Hongle Li, Weigang Liu, Juanjuan Zhao, Zhongyu Yang, Jianying Zhang. Long Non-Coding RNA FOXD2-AS1 Serves as a Potential Prognostic Biomarker for Patients With Cancer: A Meta-Analysis and Database Testing. The American Journal of the Medical Sciences 2021; 362(2): 173 doi: 10.1016/j.amjms.2021.01.020
|
| 35 |
Danira Ashraf Habashy, Merna Hatem Mohamed Hamad, Manon Ragheb, Ziad Amr Khalil, Shereen Ahmed El Sobky, Karim Adel Hosny, Gamal Esmat, Nada Magdy El-Ekiaby, Injie Omar Fawzy, Ahmed Ihab Abdelaziz. Regulation of IGF2BP1 by miR-186 and its Impact on Downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4128906
|
| 36 |
Danira Ashraf Habashy, Merna Hatem Mohamed Hamad, Manon Ragheb, Ziad Amr Khalil, Shereen Ahmed El Sobky, Karim Adel Hosny, Gamal Esmat, Nada El-Ekiaby, Injie Omar Fawzy, Ahmed Ihab Abdelaziz. Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC. Life Sciences 2022; 310: 121075 doi: 10.1016/j.lfs.2022.121075
|
| 37 |
Xuemei Lv, Miao He, Yanyun Zhao, Liwen Zhang, Wenjing Zhu, Longyang Jiang, Yuanyuan Yan, Yue Fan, Hongliang Zhao, Shuqi Zhou, Heyao Ma, Yezhi Sun, Xiang Li, Hong Xu, Minjie Wei. Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0884-0
|
| 38 |
Fahong Wu, Hangzhi Wei, Guiyuan Liu, Youcheng Zhang. Bioinformatics Profiling of Five Immune-Related lncRNAs for a Prognostic Model of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.667904
|
| 39 |
Rui Li, Chen Jin, Weiheng Zhao, Rui Liang, Huihua Xiong. Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02540-2
|
| 40 |
Reza Arefnezhad, Sara Ashna, Fatemeh Rezaei‐Tazangi, Seyed Mahdi Arfazadeh, Seyede Shabnam Seyedsalehie, Shaghayegh Yeganeafrouz, Melika Aghaei, Mandana Sanandaji, Ramin Davoodi, Sareh Ranjbar Karim Abadi, Massoud Vosough. Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate. Cell Biology International 2024; 48(5): 556 doi: 10.1002/cbin.12145
|
| 41 |
Mingxin Cui, Fengzhi Qu, Libing Wang, Xiaogang Liu, Jingkun Yu, Zhaoyuan Tang, Daming Cheng. m5C RNA methyltransferase-related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker. Cancer Biomarkers 2022; 33(3): 389 doi: 10.3233/CBM-210154
|
| 42 |
Wei Zhang, Kegong Chen, Wei Tian, Qi Zhang, Lin Sun, Yupeng Wang, Meina Liu, Qiuju Zhang. A Novel and Robust Prognostic Model for Hepatocellular Carcinoma Based on Enhancer RNAs-Regulated Genes. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.849242
|
| 43 |
Ling Zhang, Peiqiang Cai, Jingyu Hou, Ma Luo, Yonggang Li, Xinhua Jiang. Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation. Cancer Management and Research 2021; : 2785 doi: 10.2147/CMAR.S300627
|
| 44 |
Lixia Xu, Shu Chen, Qiaoqiao Li, Xinyi Chen, Yuan Xu, Yongjian Zhou, Juan Li, Zhixian Guo, Jiyuan Xing, Di Chen. Integrating bioinformatics and experimental validation to unveil disulfidptosis-related lncRNAs as prognostic biomarker and therapeutic target in hepatocellular carcinoma. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-023-03208-x
|
| 45 |
Zi-An Chen, Hui Tian, Dong-Mei Yao, Yuan Zhang, Zhi-Jie Feng, Chuan-Jie Yang. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.738477
|
| 46 |
Xuemei Lv, Yanyun Zhao, Liwen Zhang, Shuqi Zhou, Bing Zhang, Qiang Zhang, Longyang Jiang, Xueping Li, Huizhe Wu, Lin Zhao, Minjie Wei, Miao He. Development of a novel gene signature in patients without Helicobacter pylori infection gastric cancer. Journal of Cellular Biochemistry 2020; 121(2): 1842 doi: 10.1002/jcb.29419
|
| 47 |
Qingyong Xu, Hang Yin, Haijiao Ao, Xue Leng, Mingdong Liu, Yang Liu, Jianqun Ma, Xiaoyuan Wang. An 11‐lncRNA expression could be potential prognostic biomarkers in head and neck squamous cell carcinoma. Journal of Cellular Biochemistry 2019; 120(10): 18094 doi: 10.1002/jcb.29113
|
| 48 |
Chunmiao Kang, Xuanhui Jia, Hongsheng Liu. Development and validation of a RNA binding protein gene pair-associated prognostic signature for prediction of overall survival in hepatocellular carcinoma. BioMedical Engineering OnLine 2020; 19(1) doi: 10.1186/s12938-020-00812-0
|
| 49 |
Yuanyong Wang, Naixin Liang, Zhiqiang Xue, Xinying Xue. Identifying an Eight-Gene Signature to Optimize Overall Survival Prediction of Esophageal Adenocarcinoma Using Bioinformatics Analysis of ceRNA Network. OncoTargets and Therapy 2020; : 13041 doi: 10.2147/OTT.S287084
|
| 50 |
Hanyi Zeng, Chengdong Liu, Xiaohan Zhou, Li Liu. A New Prognostic Strategy Based on four DNA Repair-Associated
lncRNAs for Hepatocellular Carcinoma. Combinatorial Chemistry & High Throughput Screening 2022; 25(5): 906 doi: 10.2174/1386207324666210302091432
|
| 51 |
Huiying Liu, Jianjun Zhu, Lingling Guo, Hongjuan Zhang, Shuxiong Liu, Xiaoxia Kou, Zhiqian Zhang. Identification of a Two-lncRNA Signature with Prognostic and Diagnostic Value for Hepatocellular Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/2687455
|
| 52 |
Xiang-Xu Wang, Li-Hong Wu, Liping Ai, Wei Pan, Jing-Yi Ren, Qiong Zhang, Hong-Mei Zhang. Construction of an HCC recurrence model based on the investigation of immune-related lncRNAs and related mechanisms. Molecular Therapy - Nucleic Acids 2021; 26: 1387 doi: 10.1016/j.omtn.2021.11.006
|
| 53 |
Jing-Xian Gu, Xing Zhang, Run-Chen Miao, Xiao-Hong Xiang, Yu-Nong Fu, Jing-Yao Zhang, Chang Liu, Kai Qu. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(2): 220-232 doi: 10.3748/wjg.v25.i2.220
|
| 54 |
Haitao Jiang, Lianhe Zhao, Yunjie Chen, Liang Sun. A four‐long noncoding RNA signature predicts survival of hepatocellular carcinoma patients. Journal of Clinical Laboratory Analysis 2020; 34(9) doi: 10.1002/jcla.23377
|
| 55 |
Soudeh Ghafouri-Fard, Mahdi Gholipour, Bashdar Mahmud Hussen, Mohammad Taheri. The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.649107
|
| 56 |
Qinghua Wu, Li You, Eugenie Nepovimova, Zbynek Heger, Wenda Wu, Kamil Kuca, Vojtech Adam. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. Journal of Hematology & Oncology 2022; 15(1) doi: 10.1186/s13045-022-01292-6
|
| 57 |
Daming Cheng, Libing Wang, Fengzhi Qu, Jingkun Yu, Zhaoyuan Tang, Xiaogang Liu. Identification and construction of a 13‐gene risk model for prognosis prediction in hepatocellular carcinoma patients. Journal of Clinical Laboratory Analysis 2022; 36(5) doi: 10.1002/jcla.24377
|
| 58 |
Xiaoyu Deng, Qinghua Bi, Shihan Chen, Xianhua Chen, Shuhui Li, Zhaoyang Zhong, Wei Guo, Xiaohui Li, Youcai Deng, Yao Yang. Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma. Frontiers in Molecular Biosciences 2021; 7 doi: 10.3389/fmolb.2020.611626
|
| 59 |
Qiuhui Hu, Sheng Tai, Jicai Wang. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers. Pathology - Research and Practice 2019; 215(5): 843 doi: 10.1016/j.prp.2019.01.033
|
| 60 |
Xu Wang, Mingzhi Han, Songyu Chen, Yanfei Sun, Ruirong Tan, Bin Huang. The copper-associated protein STEAP2 correlated with glioma prognosis and immune infiltration. Frontiers in Cellular Neuroscience 2022; 16 doi: 10.3389/fncel.2022.944682
|
| 61 |
Xiaoqing Dou, Qun Zhou, Mingxiao Wen, Jiangyan Xu, Yingping Zhu, Shuzhen Zhang, Xianli Xu. RETRACTED: Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor. Frontiers in Pharmacology 2020; 10 doi: 10.3389/fphar.2019.01700
|
| 62 |
Haiping Zhao, Shiwei Zhang, Shijie Shao, Haixing Fang. Identification of a Prognostic 3-Gene Risk Prediction Model for Thyroid Cancer. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00510
|
| 63 |
Zunyi Zhang, Erlei Zhang. Conversion therapy for advanced hepatocellular carcinoma with vascular invasion: a comprehensive review. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1073531
|